Verano Holdings (VRNO) Change in Cash (2021 - 2026)
Verano Holdings (VRNO) posted quarterly Change in Cash of -$8.7 million for Q1 2026, down 143.23% year-over-year from $20.1 million in Q1 2025, and down 8463.46% quarter-over-quarter from $104000.0 in Q4 2025.
Verano Holdings (VRNO) Change in Cash (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has reported Change in Cash for 6 consecutive years, with -$8.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 143.23% year-over-year to -$8.7 million; the TTM figure through Mar 2026 stood at -$10.2 million (up 90.7% YoY), while the FY2025 annual figure was -$5.1 million, up 94.17% from the prior year.
- Change in Cash retreated to -$8.7 million in Q1 2026 per VRNO's latest filing, from $104000.0 in the prior quarter.
- Across five years, Change in Cash topped out at $44.8 million in Q4 2023 and bottomed at -$65.1 million in Q3 2024.
- Historically, Change in Cash has averaged -$1.5 million across 5 years, with a median of $7.4 million in 2023.
- Annual changes were most pronounced in 2023 — Change in Cash surged 424.81% — and 2024, when it sank 955.78%.
- Verano Holdings' Change in Cash stood at $8.5 million in 2022, then soared by 424.81% to $44.8 million in 2023, then slumped by 49.13% to $22.8 million in 2024, then plunged by 99.54% to $104000.0 in 2025, then slumped by 8463.46% to -$8.7 million in 2026.
- Business Quant data shows VRNO's Change in Cash at -$8.7 million in Q1 2026, $104000.0 in Q4 2025, and $14.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Verano Holdings | 449.04 Mn | 363.85 Mn | 99.70 Mn | 11.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.17 Mn |
| Mar 31, 2026 | -8.70 Mn |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 14.05 Mn |
| Jun 30, 2025 | -15.65 Mn |
| Mar 31, 2025 | -3.58 Mn |
| Dec 31, 2024 | 22.81 Mn |
| Sep 30, 2024 | -65.07 Mn |
| Jun 30, 2024 | -63.75 Mn |
| Mar 31, 2024 | 19.02 Mn |
| Dec 31, 2023 | 44.84 Mn |
| Sep 30, 2023 | 27.35 Mn |
| Jun 30, 2023 | 7.45 Mn |
| Mar 31, 2023 | 10.28 Mn |
| Dec 31, 2022 | 8.54 Mn |
| Sep 30, 2022 | -16.52 Mn |
| Jun 30, 2022 | -46.80 Mn |
| Mar 31, 2022 | 40.52 Mn |
| Dec 31, 2021 | 42.18 Mn |
| Sep 30, 2021 | -92.73 Mn |